Oral creatine monohydrate supplementation improves brain performance: a double-blind, placebo-controlled, cross-over trial

被引:154
|
作者
Rae, C [1 ]
Digney, AL
McEwan, SR
Bates, TC
机构
[1] Univ Sydney, Sch Mol & Microbial Biosci G08, Discipline Biochem, Sydney, NSW 2006, Australia
[2] Macquarie Univ, Macquarie Ctr Cognit Sci, N Ryde, NSW 2109, Australia
关键词
creatine; oral supplementation; intelligence; memory; brain bioenergetics;
D O I
10.1098/rspb.2003.2492
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Creatine supplementation is in widespread use to enhance sports-fitness performance, and has been trialled successfully in the treatment of neurological, neuromuscular and atherosclerotic disease. Creatine plays a pivotal role in brain energy homeostasis, being a temporal and spatial buffer for cytosolic and mitochondrial pools of the cellular energy currency, adenosine triphosphate and its regulator, adenosine diphosphate. In this work, we tested the hypothesis that oral creatine supplementation (5 g d(-1) for six weeks) would enhance intelligence test scores and working memory performance in 45 young adult, vegetarian subjects in a double-blind, placebo-controlled, cross-over design. Creatine supplementation had a significant positive effect (p < 0.0001) on both working memory (backward digit span) and intelligence (Raven's Advanced Progressive Matrices), both tasks that require speed of processing. These findings underline a dynamic and significant role of brain energy capacity in influencing brain performance.
引用
收藏
页码:2147 / 2150
页数:4
相关论文
共 50 条
  • [31] Effectiveness of Fish Roe, Snow Fungus, and Yeast Supplementation for Cognitive Function: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial
    Lin, Yung-Kai
    Lin, Yung-Hsiang
    Chiang, Chi-Fu
    Jingling, Li
    NUTRIENTS, 2023, 15 (19)
  • [32] A double-blind, placebo-controlled randomized trial of creatine for the cancer anorexia/weight loss syndrome (N02C4): an Alliance trial
    Jatoi, A.
    Steen, P. D.
    Atherton, P. J.
    Moore, D. F.
    Rowland, K. M.
    Le-Lindqwister, N. A.
    Adonizio, C. S.
    Jaslowski, A. J.
    Sloan, J.
    Loprinzi, C.
    ANNALS OF ONCOLOGY, 2017, 28 (08) : 1957 - 1963
  • [33] Premedication with melatonin: a double-blind, placebo-controlled comparison with midazolam
    Naguib, M
    Samarkandi, AH
    BRITISH JOURNAL OF ANAESTHESIA, 1999, 82 (06) : 875 - 880
  • [34] Oxytocin to modulate emotional processing in schizophrenia: A randomized, double-blind, cross-over clinical trial
    Brambilla, Michela
    Cotelli, Maria
    Manenti, Rosa
    Dagani, Jessica
    Sisti, Davide
    Rocchi, Marco
    Balestrieri, Matteo
    Pini, Stefano
    Raimondi, Sara
    Saviotti, Francesco Maria
    Scocco, Paolo
    de Girolamo, Giovanni
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2016, 26 (10) : 1619 - 1628
  • [35] A randomized, double-blind, placebo-controlled trial of coenzyme Q10 in Huntington disease
    McGarry, Andrew
    McDermott, Michael
    Kieburtz, Karl
    de Blieck, Elisabeth A.
    Beal, Flint
    Marder, Karen
    Ross, Christopher
    Shoulson, Ira
    Gilbert, Peter
    Mallonee, William M.
    Guttman, Mark
    Wojcieszek, Joanne
    Kumar, Rajeev
    LeDoux, Mark S.
    Jenkins, Mary
    Rosas, H. Diana
    Nance, Martha
    Biglan, Kevin
    Como, Peter
    Dubinsky, Richard M.
    Shannon, Kathleen M.
    O'Suilleabhain, Padraig
    Chou, Kelvin
    Walker, Francis
    Martin, Wayne
    Wheelock, Vicki L.
    McCusker, Elizabeth
    Jankovic, Joseph
    Singer, Carlos
    Sanchez-Ramos, Juan
    Scott, Burton
    Suchowersky, Oksana
    Factor, Stewart A.
    Higgins, Donald S., Jr.
    Molho, Eric
    Revilla, Fredy
    Caviness, John N.
    Friedman, Joseph H.
    Perlmutter, Joel S.
    Feigin, Andrew
    Anderson, Karen
    Rodriguez, Ramon
    McFarland, Nikolaus R.
    Margolis, Russell L.
    Farbman, Eric S.
    Raymond, Lynn A.
    Suski, Valerie
    Kostyk, Sandra
    Colcher, Amy
    Seeberger, Lauren
    NEUROLOGY, 2017, 88 (02) : 152 - 159
  • [36] A randomized, double-blind, placebo-controlled trial of lamotrigine for prescription corticosteroid effects on the human hippocampus
    Brown, E. Sherwood
    Sayed, Nasreen
    Choi, Changho
    Tustison, Nicholas
    Roberts, Jared
    Yassa, Michael A.
    Van Enkevort, Erin
    Nakamura, Alyson
    Ivleva, Elena I.
    Sunderajan, Prabha
    Khan, David A.
    Vazquez, Miguel
    McEwen, Bruce
    Kulikova, Alexandra
    Frol, Alan B.
    Holmes, Traci
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2019, 29 (03) : 376 - 383
  • [37] Efficacy of micronutrient supplementation on skin aging and seasonal variation: a randomized, placebo-controlled, double-blind study
    Fanian, Ferial
    Mac-Mary, Sophie
    Jeudy, Adeline
    Lihoreau, Thomas
    Messikh, Rafat
    Ortonne, Jean-Paul
    Sainthillier, Jean-Marie
    Elkhyat, Ahmed
    Guichard, Alexandre
    Kenari, Kamran Hejazi
    Humbert, Philippe
    CLINICAL INTERVENTIONS IN AGING, 2013, 8 : 1527 - 1537
  • [38] Daily Oral Memantine Attenuated the Severity of Borderline Personality Disorder Symptoms: A Double-Blind Placebo-Controlled, Randomized Clinical Trial
    Mohammadsadeghi, Homa
    Soleimannejad, Maryam
    Ramazi, Samira
    Shalbafan, Mohammadreza
    Ardebili, Mehrdad Eftekhar
    Vahabzadeh, Gelareh
    Ahmadirad, Nooshin
    Karimzadeh, Fariba
    IRANIAN JOURNAL OF PSYCHIATRY AND BEHAVIORAL SCIENCES, 2023, 17 (02)
  • [39] A randomized, double-blind, placebo-controlled trial of citicoline for bipolar and unipolar depression and methamphetamine dependence
    Brown, E. Sherwood
    Gabrielson, Barry
    JOURNAL OF AFFECTIVE DISORDERS, 2012, 143 (1-3) : 257 - 260
  • [40] An Acute, Double-Blind, Placebo-Controlled Cross-over Study of 320 mg and 640 mg Doses of Bacopa monnieri (CDRI 08) on Multitasking Stress Reactivity and Mood
    Benson, Sarah
    Downey, Luke A.
    Stough, Con
    Wetherell, Mark
    Zangara, Andrea
    Scholey, Andrew
    PHYTOTHERAPY RESEARCH, 2014, 28 (04) : 551 - 559